Profil Penggunaan Suplementasi Besi (Fe) pada Ibu Hamil di Rumah Sakit PKU Muhammadiyah Surabaya

Anemia defisiensi besi merupakan masalah kesehatan yang sering terjadi pada ibu hamil sehingga diperlukan suplementasi besi untuk mencegah komplikasi pada ibu dan janin. Penelitian ini bertujuan mengetahui profil penggunaan suplementasi besi (Fe) pada ibu hamil di Rumah Sakit PKU Muhammadiyah Surabaya. Penelitian
observasional deskriptif dengan pendekatan retrospektif dilakukan pada 324 rekam medis ibu hamil periode Januari–Desember 2024. Hasil penelitian menunjukkan
mayoritas pasien berusia 20–35 tahun (75,6%), berada pada trimester III (61,7%), dan mengalami anemia sedang. Suplemen yang paling banyak digunakan adalah Fe gluconate (30 mg), dengan frekuensi penggunaan terbanyak 1 kali sehari dan durasi
11–20 hari. Sebagian besar penggunaan suplementasi besi telah sesuai dengan rekomendasi WHO dan Kementerian Kesehatan RI, namun masih ditemukan
penggunaan Fe fumarate 7,8 mg, Fe fumarate 16,5 mg, dan Ferronyl Iron 18 mg yang belum memenuhi rekomendasi minimal 30 mg besi elemental per hari apabila digunakan sebagai terapi tunggal. Disimpulkan bahwa penggunaan suplementasi besi pada ibu hamil didominasi Fe gluconate, dengan sebagian besar telah sesuai standar, meskipun masih terdapat beberapa sediaan yang memerlukan evaluasi dosis untuk memenuhi kebutuhan besi selama kehamilan.

===========================================================================================

Iron-deficiency anemia is a common health problem among pregnant women, making iron supplementation necessary to prevent complications in both the mother and the fetus. This study aimed to determine the profile of iron (Fe) supplementation use among pregnant women at PKU Muhammadiyah Hospital in Surabaya. A descriptive observational study with a retrospective approach was conducted on 324 medical records of pregnant women from January to December 2024. The results showed that the majority of patients were aged 20–35 years (75.6%), were in the third trimester (61.7%), and had moderate anemia. The most commonly used supplement was Fe gluconate (30 mg), with the most frequent dosage being once daily and a duration of
11–20 days. Most iron supplementation was in accordance with WHO and Indonesian Ministry of Health recommendations; however, the use of 7.8 mg iron fumarate, 16.5 mg iron fumarate, and 18 mg Ferronyl Iron was still observed, which does not meet the minimum recommendation of 30 mg of elemental iron per day when used as monotherapy. It is concluded that the use of iron supplementation among pregnant women is dominated by iron gluconate, with the majority meeting standards, although there are still some formulations that require dose evaluation to meet iron requirements
during pregnancy.